Search results
Author(s):
Milton Packer
Added:
4 weeks ago
AHA Scientific Sessions 2025 - Dr Milton Packer (Baylor University Medical Center, US) joins us to discuss his novel unifying hypothesis that heart failure with preserved ejection fraction arises primarily from visceral adipose tissue dysfunction and altered adipokine signaling, rather than as a heterogeneous disorder driven by multiple comorbidities.Interview Questions:Can you explain the core…
View more
Author(s):
Deesha Patel
,
Makrina D Savvidou
Added:
1 year ago
Dominik Linz
Job title: Cardiologist and Associate Professor
Author
Naricha Chirakalwasan
Research Area(s) / Expertise:
Author
Andrew R Spector
Author
Rami Khayat
Author
Dr Martino F Pengo
Research Area(s) / Expertise:
Author
Author(s):
Stephen Nicholls
Added:
1 month ago
AHA Scientific Sessions 2025 - Phase 1 results show the CRISPR-Cas9 gene editing therapy is a safe treatment option targeting ANGPTL3 in patients with lipid disorders.Prof Stephen Nicholls (Monash Victorian Heart Institute, Clayton, AU) joins us to share results from a first-in-human phase 1 trial investigating a one-time infusion of CTX310, a CRISPR-Cas9 gene editing therapy, at different doses…
View more
Ahmed M Salem
Author